Búsqueda | Portal de Búsqueda de la BVS España

1.

Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.

Telli, M L; Stover, D G; Loi, S; Aparicio, S; Carey, L A; Domchek, S M; Newman, L; Sledge, G W; Winer, E P.

Breast Cancer Res Treat; 171(1): 21-31, 2018 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-29736741

2.

Research needs in breast cancer.

Cardoso, F; Harbeck, N; Barrios, C H; Bergh, J; Cortés, J; El Saghir, N; Francis, P A; Hudis, C A; Ohno, S; Partridge, A H; Sledge, G W; Smith, I E; Gelmon, K A.

Ann Oncol; 28(2): 208-217, 2017 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-27831505

3.

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).

Cardoso, F; Paluch-Shimon, S; Senkus, E; Curigliano, G; Aapro, M S; André, F; Barrios, C H; Bergh, J; Bhattacharyya, G S; Biganzoli, L; Boyle, F; Cardoso, M-J; Carey, L A; Cortés, J; El Saghir, N S; Elzayat, M; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Gligorov, J; Haidinger, R; Harbeck, N; Hu, X; Kaufman, B; Kaur, R; Kiely, B E; Kim, S-B; Lin, N U; Mertz, S A; Neciosup, S; Offersen, B V; Ohno, S; Pagani, O; Prat, A; Penault-Llorca, F; Rugo, H S; Sledge, G W; Thomssen, C; Vorobiof, D A; Wiseman, T; Xu, B; Norton, L; Costa, A; Winer, E P.

Ann Oncol; 31(12): 1623-1649, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-32979513

4.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

Schneider, B P; Li, L; Shen, F; Miller, K D; Radovich, M; O'Neill, A; Gray, R J; Lane, D; Flockhart, D A; Jiang, G; Wang, Z; Lai, D; Koller, D; Pratt, J H; Dang, C T; Northfelt, D; Perez, E A; Shenkier, T; Cobleigh, M; Smith, M L; Railey, E; Partridge, A; Gralow, J; Sparano, J; Davidson, N E; Foroud, T; Sledge, G W.

Br J Cancer; 111(6): 1241-8, 2014 Sep 09.

Artículo en Inglés | MEDLINE | ID: mdl-25117820

5.

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4).

Cardoso, F; Senkus, E; Costa, A; Papadopoulos, E; Aapro, M; André, F; Harbeck, N; Aguilar Lopez, B; Barrios, C H; Bergh, J; Biganzoli, L; Boers-Doets, C B; Cardoso, M J; Carey, L A; Cortés, J; Curigliano, G; Diéras, V; El Saghir, N S; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Johnston, S R D; Kaufman, B; Koppikar, S; Krop, I E; Mayer, M; Nakigudde, G; Offersen, B V; Ohno, S; Pagani, O; Paluch-Shimon, S; Penault-Llorca, F; Prat, A; Rugo, H S; Sledge, G W; Spence, D; Thomssen, C; Vorobiof, D A; Xu, B; Norton, L; Winer, E P.

Ann Oncol; 29(8): 1634-1657, 2018 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-30032243

6.

A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.

Miller, K D; O'Neill, A; Perez, E A; Seidman, A D; Sledge, G W.

Ann Oncol; 23(2): 331-7, 2012 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-21821545

7.

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

Nakshatri, H; Bhat-Nakshatri, P; Martin, D A; Goulet, R J; Sledge, G W.

Mol Cell Biol; 17(7): 3629-39, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9199297

8.

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.

Sledge, G W; Qulali, M; Goulet, R; Bone, E A; Fife, R.

J Natl Cancer Inst; 87(20): 1546-50, 1995 Oct 18.

Artículo en Inglés | MEDLINE | ID: mdl-7563189

9.

Establishment in long term culture of megakaryocytic leukemia cells (EST-IU) from the marrow of a patient with leukemia and a mediastinal germ cell neoplasm.

Sledge, G W; Glant, M; Jansen, J; Heerema, N A; Roth, B J; Goheen, M; Hoffman, R.

Cancer Res; 46(4 Pt 2): 2155-9, 1986 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-3004722

10.

Relation of proliferative activity to survival in patients with advanced germ cell cancer.

Sledge, G W; Eble, J N; Roth, B J; Wuhrman, B P; Fineberg, N; Einhorn, L H.

Cancer Res; 48(13): 3864-8, 1988 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-2837326

11.

Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.

Edwards, D P; Grzyb, K T; Dressler, L G; Mansel, R E; Zava, D T; Sledge, G W; McGuire, W L.

Cancer Res; 46(3): 1306-17, 1986 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3510721

12.

Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.

Fleck, J F; Sledge, G W; Benenati, S V; Frolik, C A; Roth, B J; Hirsch, K S.

Cancer Res; 51(16): 4395-401, 1991 Aug 15.

Artículo en Inglés | MEDLINE | ID: mdl-1678315

13.

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Sweeney, C J; Miller, K D; Sissons, S E; Nozaki, S; Heilman, D K; Shen, J; Sledge, G W.

Cancer Res; 61(8): 3369-72, 2001 Apr 15.

Artículo en Inglés | MEDLINE | ID: mdl-11309294

14.

Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death.

Nozaki, S; Sledge, G W; Nakshatri, H.

Oncogene; 20(17): 2178-85, 2001 04 19.

Artículo en Inglés | MEDLINE | ID: mdl-11360202

15.

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.

Patel, N M; Nozaki, S; Shortle, N H; Bhat-Nakshatri, P; Newton, T R; Rice, S; Gelfanov, V; Boswell, S H; Goulet, R J; Sledge, G W; Nakshatri, H.

Oncogene; 19(36): 4159-69, 2000 Aug 24.

Artículo en Inglés | MEDLINE | ID: mdl-10962577

16.

Cisplatin as first-line therapy for metastatic breast cancer.

Sledge, G W; Loehrer, P J; Roth, B J; Einhorn, L H.

J Clin Oncol; 6(12): 1811-4, 1988 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-3199166

17.

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

Clark, G M; Sledge, G W; Osborne, C K; McGuire, W L.

J Clin Oncol; 5(1): 55-61, 1987 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-3806159

18.

Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study.

Sledge, G W; Hu, P; Falkson, G; Tormey, D; Abeloff, M.

J Clin Oncol; 18(2): 262-6, 2000 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-10637238

19.

Redefining the target: chemotherapeutics as antiangiogenics.

Miller, K D; Sweeney, C J; Sledge, G W.

J Clin Oncol; 19(4): 1195-206, 2001 Feb 15.

Artículo en Inglés | MEDLINE | ID: mdl-11181686

20.

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

Gordon, M S; Margolin, K; Talpaz, M; Sledge, G W; Holmgren, E; Benjamin, R; Stalter, S; Shak, S; Adelman, D.

J Clin Oncol; 19(3): 843-50, 2001 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-11157038

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: